New drug smilagenin to be evaluated through EXPERTS-ALS platform
A new candidate treatment for motor neuron disease (MND) will [...]
Neflamapimod to be evaluated through EXPERTS-ALS platform
A potential new treatment for motor neuron disease (MND) will [...]
Our first three years: what we’ve achieved together so far
As we enter the next phase of funding, it’s important to look [...]
UK MND RI biomarkers research programme reaches recruitment target
The UK MND RI’s biosampling platform has now recruited 212 [...]
Could biomarkers transform ALS clinical trials and accelerate treatment development?
A new systematic review highlights how biomarkers, biological indicators of [...]
Research snapshot: What do people with MND need when deciding about genetic testing?
A new study has explored the experiences of people with [...]
